Hypoglycemic Agents: all 3,927 studies that test it
Page 35 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- 20 Week Bridging Study in Type II DMCompletedNCT00563225Phase 3
- Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsCompletedNCT00562250Phase 1
- Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)CompletedNCT00562172Phase 4
- Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 DiabetesCompletedNCT00562133Phase 3
- Study of Vanadium Supplement in Patients With Impaired Glucose ToleranceCompletedNCT00561132Phase 3
- The Effect of Adding Metformin to the Treatment of Hepatitis CCompletedNCT00560690Phase 4
- Second-Line Treatments for Anovulatory Infertility in PCOS PatientsCompletedNCT00558077Phase 4
- Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After EatingCompletedNCT00553488Phase 2
- Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 DiabetesCompletedNCT00553020Phase 4
- Glycemic Optimization Treatment StudyCompletedNCT00552370Phase 4
- Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes MellitusCompletedNCT00551590Phase 1
- Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone MaleateCompletedNCT00551564Phase 1
- 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. GlargineCompletedNCT00551538Phase 4
- Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCompletedNCT00551356Phase 3
- Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 DiabetesCompletedNCT00549874Not applicable
- Treatment Insulin Resistence in HCV G-1 PatientCompletedNCT00546442Phase 4
- Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes MellitusCompletedNCT00545857Phase 1
- Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)TerminatedNCT00543361Phase 3
- Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir InjectionsCompletedNCT00542399Phase 4
- PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+LisproCompletedNCT00540709Phase 4
- Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics StudyCompletedNCT00539448Phase 4
- A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsCompletedNCT00538486Phase 4
- 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes MellitusCompletedNCT00537251Phase 3
- Comparison of Apidra to Regular Insulin in Hospitalized PatientsCompletedNCT00528918Not applicable
- Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes MellitusCompletedNCT00526513Phase 4
- A Study Of BRL49653C For The Treatment Of Type 2 DiabetesCompletedNCT00523913Phase 3
- Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
- Effects of Rosiglitazone on Serum Ghrelin and Peptide YY LevelsCompletedNCT00522470Phase 4
- Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 DiabetesCompletedNCT00522210Not applicable
- Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedNCT00521820Phase 3
- Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedNCT00521742Phase 3
- The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedNCT00521690Phase 4
- Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusCompletedNCT00519142Phase 3
- Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese AdultsCompletedNCT00518466Phase 1
- Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline GlargineCompletedNCT00518427Phase 4
- Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?Status unknownNCT00516880Not applicable
- Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DMCompletedNCT00515801Phase 2/3
- Metabolic Effect of Insulin Aspart and Human Insulin in Different DosesCompletedNCT00513643Phase 1
- Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCompletedNCT00513630Phase 4
- Lyspro Insulin vs Regular Insulin in Cirrhotic PatientsCompletedNCT00513201Phase 4
- The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in SubjectsCompletedNCT00511823Phase 1
- Influence of Pioglitazone for Renal Transplant Function in DiabeticsCompletedNCT00507494Phase 3
- Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic ControlCompletedNCT00506194Not applicable
- Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 DiabetesWithdrawnNCT00505882Phase 4
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
- A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 DiabetesCompletedNCT00502138Phase 4
- Metformin in Infertile PCOS PatientsStatus unknownNCT00501904Phase 4
- Metformin Administration in Infertile Anovulatory PCOS PatientsWithdrawnNCT00501787Phase 4
- Effects of Sitagliptin on Gastric Emptying in Healthy SubjectsCompletedNCT00501657Phase 1
- Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminCompletedNCT00501020Phase 4
- Rosiglitazone on Microalbuminuria in Type 2 DiabeticsCompletedNCT00500955Phase 3
- Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNCT00499707Phase 3
- Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartCompletedNCT00494988Phase 4
- Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT00494884Phase 3
- The Effect of Pioglitazone on Neointima Volume and Inflammatory MarkersCompletedNCT00494559Phase 4
- Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedNCT00494312Phase 4
- A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic SteatohepatitisCompletedNCT00492700Phase 2
- Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsCompletedNCT00491725Phase 4
- Hypoglycemia Counterregulation and Symptom Perception With Insulin DetemirTerminatedNCT00490893Phase 4
- A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00490854Phase 2/3
- Effect of Hyperglycemia on Gastric Emptying Interactions With PramlintideCompletedNCT00489645Not applicable
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsCompletedNCT00489229Phase 3
- APIDRA Registration StudyCompletedNCT00489190Phase 4
- DOMME Dose Optimization Multicentric Mexican EvaluationCompletedNCT00488527Phase 4
- Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL StudyCompletedNCT00486187Not applicable
- Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)CompletedNCT00485056Phase 4
- One Year Glargine Treatment in CFRD Children and AdolescentsCompletedNCT00483769Phase 4
- Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected PatientsCompletedNCT00483392Not applicable
- Comparison Between Pioglitazone and SES With type2 DMCompletedNCT00482183Phase 2/3
- A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)CompletedNCT00481663Phase 2
- Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart DiseaseCompletedNCT00479986Phase 4
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes MellitusCompletedNCT00477581Phase 4
- Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00476437Phase 3
- Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00472953Phase 3
- Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?Status unknownNCT00472875Phase 4
- Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic StrokeCompletedNCT00472381Phase 2/3
- Treatment of Anovulatory Infertility in PCOS PatientsCompletedNCT00471523Phase 4
- Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesTerminatedNCT00469586Phase 3
- A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus MetforminCompletedNCT00468039Phase 3
- Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsTerminatedNCT00467636Not applicable
- Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes MellitusCompletedNCT00467376Phase 3
- Sub-Cutaneous Insulin in Hyperglycaemic EmergenciesWithdrawnNCT00467246Not applicable
- Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With MetforminCompletedNCT00466622Phase 3
- Sitagliptin Treatment in Patients With Type 2 DM After Kidney TransplantCompletedNCT00466518Not applicable
- Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLSTerminatedNCT00465296Phase 3
- Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol DependenceWithdrawnNCT00463775Phase 3
- The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes MellitusCompletedNCT00463502Phase 4
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedNCT00462202Phase 3
- Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOSStatus unknownNCT00461643Phase 4
- Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic PatientsCompletedNCT00461617Phase 3
- The Effect of Pramlintide on Meal Time Insulin BolusCompletedNCT00460304Not applicable
- The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD PatientsCompletedNCT00459940Not applicable
- A Comparison Between Glargine and Detemir Insulin in Type 2 DiabetesCompletedNCT00457093Not applicable
- Rosiglitazone and Insulin Resistance in Renally Impaired PatientsTerminatedNCT00452166Phase 3
- Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 DiabetesCompletedNCT00451620Phase 2
- Metformin and Oral Contraceptives in PCOSCompletedNCT00451568Phase 4
- Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight GainCompletedNCT00451399Phase 4
- Sitagliptin in the ElderlyCompletedNCT00451113Phase 2
- Changes of the Infusion Rate in Insulin Pump TreatmentCompletedNCT00449839Phase 4
- Novel Pharmacotherapy for Dual DependenceStatus unknownNCT00448825Phase 3